A New Tool to Promote Patient's Engagement in Their Healthcare Process
Development and Testing of a Patient's Decision Aid for Early Breast Cancer: a New Tool to Promote Patient's Engagement in Their Healthcare Process
European Institute of Oncology
180 participants
Jan 22, 2025
OBSERVATIONAL
Conditions
Summary
Women diagnosed with early-stage breast cancer need to make a decision about the therapeutic treatment to undertake. Since multiple factors can influence this decision, it is necessary to develop a decision-making support tool to assist them in making this choice. Main Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.
Eligibility
Inclusion Criteria5
- be 18 or older;
- have received/receive diagnosis of resectable breast cancer in the early stage;
- women treated or who will undergo oncological treatment for early breast cancer;
- demonstrate the absence of psychopathological features.
- be willing and able to provide written informed consent/assent for the trial
Exclusion Criteria4
- breast cancer patients who showed physical or psychological issues, as well as cognitive impairments that prohibited their participation in this type of study;
- neurological or psychiatric disorders that may compromise the patients' ability to take part in the study.
- Distant metastases from breast cancer or locally advanced/unresectable disease
- Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Interventions
healthcare professionals (HCPs) targeted, including team members: we will involve 30 physicians (who are involved in the process of care towards patients with early breast cancer (10 oncologists, 10 breast surgeon, and 10 breast radiologists specifically) for the semi-structured interviews
Participants will receive via mail the final version of the PDA and a Qualtrics link with a battery of questionnaires
Participants will receive only the online link with the battery of questionnaires
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06762496